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ABSTRACT 
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 When mice lacking the winged helix transcription factor Foxi1 were compared to their wt 
littermates in their response to acidic load, we discovered that Foxi1 deficient mice develop distal renal 
tubular acidosis (dRTA). Moreover, during breeding we observed the inability of Foxi1-/- males to 
generate offspring, indicating male infertility. In the light of these observations, together with our previous 
results from the inner ear of Foxi1-/- mice, we set out to examine the biological importance of Foxi1 in the 
inner ear, kidney and the epididymis. In this thesis we assess the expression pattern of Foxi1 and its 
potential downstream target genes in these three different tissues by using Northern blot analyses, in situ 
hybridization and immunohistochemistry. We demonstrated that Foxi1 is exclusively expressed in cells 
positive for the “kidney specific” vATPase subunits B1and a4, as well as the anion exchangers AE1 and 
pendrin, all characteristics for acid/base regulating cells of the inner ear, kidney and epididymis, called 
“mitochondria rich” cells. We present evidence that Foxi1 is required for the expression of these genes. 
Furthermore, in transfection experiments and in electrophoretic mobility shift assays (EMSA) we 
established direct transcriptional activation of promoter constructs by Foxi1. This activation was abolished 
when specific Foxi1 cis-elements on the promoters were mutated.  
   
 Previously we have shown that mice with target disruption of the Foxi1 locus exhibit severe 
cochlear and vestibular malformation and that Foxi1 is expressed in endolymphatic epithelial cells 
important for regulation of volume and composition of endolymph fluid. We have also shown that pendrin 
is missing from endolymphatic epithelium in Foxi1 deficient mice, making human FOXI1 a potential 
transcriptional activator of the gene coding for pendrin, the SLC26A4 gene. While recessive mutations in 
the SLC26A4 gene are known to be responsible for Pendred syndrome (PS) and non-syndromic hearing 
loss associated with enlarged vestibular aqueduct (EVA), a large percentage of patients with this 
phenotype lack mutations in the SLC26A4 coding region in one or both alleles. We have identified and 
characterized a key transcriptional regulatory element in the SLC26A4 promoter that binds FOXI1. 
Moreover, we have identified six PS or non-syndromic EVA patients with mutations in FOXI1 that 
inhibits its activation of SLC26A4 transcription 
   
 In summary, we present molecular data showing that Foxi1 is required for the expression of some of 
the most important transporter molecules of acid-base regulation in the inner ear, kidney and epididymis, 
establishing Foxi1 as an essential regulator of fluid homeostasis in these organs. Hence, mice deficient for 
Foxi1, beside their early onset deafness, develop dRTA and male infertility. We also demonstrate that 
mutations in the human FOXI1 gene are involved in pathogenetic mechanisms underlying human 
deafness. Finally, these results together with our earlier findings in mice support the hypothesis that 
mutations in the human FOXI1 gene might prove to cause a sensorineural deafness syndrome with distal 
renal tubular acidosis and male infertility.  
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